Jhandewalas Foods Fund Raise of ₹37.16 Cr

Jhandewalas Foods Other Announcement

Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.

Jhandewalas Foods Management Change

Jhandewalas Foods Limited reported the resignation of Shipra Gandhi as Company Secretary and Compliance Officer, effective June 16, 2026, citing personal reasons.

Jhandewalas Foods Other Announcement

The company submitted its quarterly shareholding pattern as mandated by SEBI Regulation 31. This is a standard periodic regulatory disclosure.

Jhandewalas Foods Price Movement Clarification

Jhandewalas Foods Limited has responded to an exchange query, stating it is unaware of any specific reasons for recent share price movements, which are market-driven.

Jhandewalas Foods Annual General Meeting

Jhandewalas Foods Limited received ROC approval for a three-month extension to hold its Annual General Meeting. The meeting for FY 2025-26 can now be convened by December 31, 2026.

Jhandewalas Foods Board Meeting Outcome

Jhandewalas Foods Limited's board approved seeking an extension from the ROC for its FY26 Annual General Meeting. This follows the non-convening of the meeting originally scheduled for July 2026.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.